scholarly article | Q13442814 |
P356 | DOI | 10.3109/10611860008997907 |
P698 | PubMed publication ID | 11328657 |
P2093 | author name string | Villarroya H | |
Irache JM | |||
Merodio M | |||
Mirshahi M | |||
Eclancher F | |||
P2860 | cites work | Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomes | Q43459944 |
Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats | Q45803643 | ||
Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens | Q46372263 | ||
Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier | Q46918469 | ||
Early detection of liposome brain localization in rat experimental allergic encephalomyelitis | Q48220773 | ||
Myelin protein expression in lymphoid tissues: implications for peripheral tolerance | Q48363174 | ||
Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers | Q48379162 | ||
Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein | Q48608889 | ||
Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. | Q52507201 | ||
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis | Q53438445 | ||
The role of magnetic resonance techniques in understanding and managing multiple sclerosis | Q32067232 | ||
Herpesviruses--a rationale for antiviral treatment in multiple sclerosis | Q33631998 | ||
Determinants of passive drug entry into the central nervous system | Q33851314 | ||
Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis | Q33865528 | ||
Blood-brain barrier permeability to small and large molecules | Q33904234 | ||
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems | Q33904251 | ||
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis | Q35455319 | ||
Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis | Q36802175 | ||
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats | Q38548001 | ||
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats | Q41348774 | ||
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages | Q42017099 | ||
P433 | issue | 5 | |
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 289-303 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Journal of Drug Targeting | Q6295099 |
P1476 | title | Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis | |
P478 | volume | 8 |
Q37561363 | Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain |
Q38896543 | Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis. |
Q35082117 | Biodegradable nanoparticles for drug and gene delivery to cells and tissue |
Q39017307 | Biopolymeric nanoparticles |
Q33682239 | Centrally Administered Pertussis Toxin Inhibits Microglia Migration to the Spinal Cord and Prevents Dissemination of Disease in an EAE Mouse Model |
Q36690735 | Cessation of blood-to-brain influx of interleukin-15 during development of EAE |
Q37890639 | Nanomedicine: novel approaches in human and veterinary therapeutics |
Q44325852 | Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis. |
Search more.